← FDA Drug Approvals (Drugs@FDA)

AMPICILLIN AND SULBACTAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA SPECLTS · Approved 2010-09-20

Drug application

FDA Application #

ANDA090349

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMPICILLIN AND SULBACTAM

Generic name

AMPICILLIN SODIUM AND SULBACTAM SODIUM

Active ingredients

AMPICILLIN SODIUM; SULBACTAM SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

EUGIA PHARMA SPECLTS

Manufacturer

Eugia US LLC

First approval

2010-09-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown